EpidEMcat is the study of the epidemiology of Multiple Sclerosis in Catalonia. It aims to characterize the disease at a population level in terms of incidence, prevalence, geographical distribution and evolution over time. These results are useful from a scientific and health management point of view and allows us to compare our region with others at a global level.
The epidEMcat, was launched in June 2008 and is led jointly by the CEM-Cat (Multiple Sclerosis Center of Catalonia) and the Epidemiology Unit of the Hospital Vall d’Hebron and has the support of the Department of Salut de la Generalitat de Catalunya and the Multiple Sclerosis Foundation (FEM). EPIDEMCAT has the scientific advice of the CEM-Cat's Medical Advisory Board represented by neurologists specializied in the management of MS in Catalonia.